Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
Feng X, Wu WY, Onwuka JU, Haider Z, Alcala K, Smith-Byrne K, Zahed H, Guida F, Wang R, Bassett JK, Stevens V, Wang Y, Weinstein S, Freedman ND, Chen C, Tinker L, Nøst TH, Koh WP, Muller D, Colorado-Yohar SM, Tumino R, Hung RJ, Amos CI, Lin X, Zhang X, Arslan AA, Sánchez MJ, Sørgjerd EP, Severi G, Hveem K, Brennan P, Langhammer A, Milne RL, Yuan JM, Melin B, Johansson M, Robbins HA, Johansson M. Feng X, et al. Among authors: alcala k. J Natl Cancer Inst. 2023 Sep 7;115(9):1050-1059. doi: 10.1093/jnci/djad071. J Natl Cancer Inst. 2023. PMID: 37260165 Free PMC article.
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Huang JY, Larose TL, Luu HN, Wang R, Fanidi A, Alcala K, Stevens VL, Weinstein SJ, Albanes D, Caporaso NE, Purdue MP, Ziegler RG, Freedman ND, Lan Q, Prentice RL, Pettinger M, Thomson CA, Cai Q, Wu J, Blot WJ, Shu XO, Zheng W, Arslan AA, Zeleniuch-Jacquotte A, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, Han J, Giles GG, Hodge AM, Severi G, Johansson M, Grankvist K, Langhammer A, Hveem K, Xiang YB, Li HL, Gao YT, Visvanathan K, Ueland PM, Midttun Ø, Ulvi A, Buring JE, Lee IM, Sesso HD, Gaziano JM, Manjer J, Relton C, Koh WP, Brennan P, Johansson M, Yuan JM. Huang JY, et al. Among authors: alcala k. Int J Cancer. 2020 May 1;146(9):2394-2405. doi: 10.1002/ijc.32555. Epub 2019 Jul 22. Int J Cancer. 2020. PMID: 31276202 Free PMC article.
Systemic inflammation markers and cancer incidence in the UK Biobank.
Nøst TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, Johansson M. Nøst TH, et al. Among authors: alcala k. Eur J Epidemiol. 2021 Aug;36(8):841-848. doi: 10.1007/s10654-021-00752-6. Epub 2021 May 25. Eur J Epidemiol. 2021. PMID: 34036468 Free PMC article.
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
Guida F, Tan VY, Corbin LJ, Smith-Byrne K, Alcala K, Langenberg C, Stewart ID, Butterworth AS, Surendran P, Achaintre D, Adamski J, Amiano P, Bergmann MM, Bull CJ, Dahm CC, Gicquiau A, Giles GG, Gunter MJ, Haller T, Langhammer A, Larose TL, Ljungberg B, Metspalu A, Milne RL, Muller DC, Nøst TH, Pettersen Sørgjerd E, Prehn C, Riboli E, Rinaldi S, Rothwell JA, Scalbert A, Schmidt JA, Severi G, Sieri S, Vermeulen R, Vincent EE, Waldenberger M, Timpson NJ, Johansson M. Guida F, et al. Among authors: alcala k. PLoS Med. 2021 Sep 20;18(9):e1003786. doi: 10.1371/journal.pmed.1003786. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34543281 Free PMC article.
The relationship between blood pressure and risk of renal cell carcinoma.
Alcala K, Mariosa D, Smith-Byrne K, Nasrollahzadeh Nesheli D, Carreras-Torres R, Ardanaz Aicua E, Bondonno NP, Bonet C, Brunström M, Bueno-de-Mesquita B, Chirlaque MD, Christakoudi S, Heath AK, Kaaks R, Katzke V, Krogh V, Ljungberg B, Martin RM, May A, Melander O, Palli D, Rodriguez-Barranco M, Sacerdote C, Stocks T, Tjønneland A, Travis RC, Vermeulen R, Chanock S, Purdue M, Weiderpass E, Muller D, Brennan P, Johansson M. Alcala K, et al. Int J Epidemiol. 2022 Aug 10;51(4):1317-1327. doi: 10.1093/ije/dyac042. Int J Epidemiol. 2022. PMID: 35312764 Free PMC article.
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.
Robbins HA, Alcala K, Moez EK, Guida F, Thomas S, Zahed H, Warkentin MT, Smith-Byrne K, Brhane Y, Muller D, Feng X, Albanes D, Aldrich MC, Arslan AA, Bassett J, Berg CD, Cai Q, Chen C, Davies MPA, Diergaarde B, Field JK, Freedman ND, Huang WY, Johansson M, Jones M, Koh WP, Lam S, Lan Q, Langhammer A, Liao LM, Liu G, Malekzadeh R, Milne RL, Montuenga LM, Rohan T, Sesso HD, Severi G, Sheikh M, Sinha R, Shu XO, Stevens VL, Tammemägi MC, Tinker LF, Visvanathan K, Wang Y, Wang R, Weinstein SJ, White E, Wilson D, Yuan JM, Zhang X, Zheng W, Amos CI, Brennan P, Johansson M, Hung RJ. Robbins HA, et al. Among authors: alcala k. Ann Epidemiol. 2023 Jan;77:1-12. doi: 10.1016/j.annepidem.2022.10.014. Epub 2022 Oct 29. Ann Epidemiol. 2023. PMID: 36404465 Free PMC article.
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis.
Feng X, Muller DC, Zahed H, Alcala K, Guida F, Smith-Byrne K, Yuan JM, Koh WP, Wang R, Milne RL, Bassett JK, Langhammer A, Hveem K, Stevens VL, Wang Y, Johansson M, Tjønneland A, Tumino R, Sheikh M, Johansson M, Robbins HA. Feng X, et al. Among authors: alcala k. EBioMedicine. 2023 Jun;92:104623. doi: 10.1016/j.ebiom.2023.104623. Epub 2023 May 24. EBioMedicine. 2023. PMID: 37236058 Free PMC article.
The blood proteome of imminent lung cancer diagnosis.
Lung Cancer Cohort Consortium (LC3). Lung Cancer Cohort Consortium (LC3). Nat Commun. 2023 Jun 1;14(1):3042. doi: 10.1038/s41467-023-37979-8. Nat Commun. 2023. PMID: 37264016 Free PMC article.
13 results